|
TMED10P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.125570E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.216570E-01 |
| Normal-vs-Stage2 |
7.129000E-01 |
| Normal-vs-Stage3 |
1.738560E-01 |
| Normal-vs-Stage4 |
2.627600E-01 |
| Stage1-vs-Stage2 |
6.612400E-01 |
| Stage1-vs-Stage3 |
6.855400E-01 |
| Stage1-vs-Stage4 |
6.826400E-01 |
| Stage2-vs-Stage3 |
5.136200E-01 |
| Stage2-vs-Stage4 |
5.277000E-01 |
| Stage3-vs-Stage4 |
8.917600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.895600E-01 |
| Normal-vs-AfricanAmerican |
1.664930E-03 |
| Normal-vs-Asian |
5.602400E-02 |
| Caucasian-vs-AfricanAmerican |
1.236150E-02 |
| Caucasian-vs-Asian |
4.154800E-01 |
| AfricanAmerican-vs-Asian |
8.739800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.748000E-02 |
| Normal-vs-Female |
9.891400E-01 |
| Male-vs-Female |
7.111900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.791600E-02 |
| Normal-vs-Extreme_Weight |
1.008170E-02 |
| Normal-vs-Obese |
3.348000E-01 |
| Normal-vs-Extreme_Obese |
1.181600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.595600E-01 |
| Normal_Weight-vs-Obese |
3.576200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.484600E-01 |
| Extreme_Weight-vs-Obese |
1.663160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.117800E-01 |
| Obese-vs-Extreme_Obese |
5.444400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.490200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.618400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.567880E-02 |
| Normal-vs-Age(81-100Yrs) |
7.150800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.150200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.893420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.242400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.770200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.142200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.831800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.796830E-01 |
| Normal-VS-Type2 PRCC |
9.463300E-03 |
| Normal-VS-KIRP CIMP |
1.772180E-01 |
| Normal-VS-Unclassified PRCC |
6.280400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.210970E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.215200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.611820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.321800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.260300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.308400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.158500E-03 |
| Normal-vs-N1 |
1.720420E-01 |
| Normal-vs-N2 |
3.842400E-02 |
| N0-vs-N1 |
4.146000E-01 |
| N0-vs-N2 |
6.034600E-01 |
| N1-vs-N2 |
3.431200E-01 |
|
|
